Peethaambaran Kunnathoor, Chennai Saturday, January 24, 2026, 08:00 Hrs [IST] ...

The PBM measures included in the bill have been championed by Earl L. “Buddy” Carter, a Republican from Georgia and pharmacist, who has long tried to pass legislation to address business practices of ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

Kapiva, India's first modern holistic Ayurvedic brand for millennials, today announced the launch of the Kapiva Innovation ...

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 23 scientific posters at Maui Derm Hawaii 2026 (Jan. 25-29), showcasing a comprehensive body of evidence across ...

Astellas' CEO said he doesn't want to make acquisitions simply to fill a revenue gap. Takeda is preparing for Trintellix's U.S. patent expiry with a round of layoffs. | Astellas CEO said he doesn't ...

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing ...

January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences ...

Industry leaders in pharma and MedTech are urging the government to establish a structured funding framework for R&D ahead of ...

“There were 11 healthcare M&A deals worth more than $1bn in enterprise value last year,” says Chuck Adams, global head of Citi’s healthcare, consumer and retail group. “We advised on seven of them.” ...

As more drugs go subcutaneous, CEO of Phillips Medisize, Tony Bedford, believes that high-dose biologics will become a prevalent choice for drugmakers.

Suraj had completed a Diploma in Pharmacy (D.Pharm) and had been preparing for NEET, with the aim of pursuing an MBBS degree.| India News ...